Helping you make wiser investment decisions

Pharmaceuticals, health and wellness

Viatris, Biocon snare historic interchangeability tag in diabetes for Lantus biosimilar

Biosimilars have been quietly moderating drug prices in the background, Bernstein analyst Ronny Gal said in a recent report. Now, armed with their first biosimilar green light of 2021, Biocon and Viatris, the company born from the combination of Mylan and Pfizer’s Upjohn unit, are plotting to disrupt the historically pricey insulin market.  The FDA on […]

Straight talk: Pfizer translates high science into plain language to make study data easier to read

Finding clinical trial results for a specific drug can be challenging—but reading through them can be even more daunting. Scientific lingo and tongue-twisting terms can frustrate even the most intelligent patient. Pfizer’s been working on the issue for a decade, but is now expanding its efforts. In May, it started sharing clinical study results in plain language in a searchable […]

Black women’s group sues J&J over targeted talc marketing—and demands new ads to counteract the old

An advocacy group says Johnson & Johnson has yet to make things right with Black women after years of targeted talc powder advertising—so they’re suing. The National Council of Negro Women filed a lawsuit this week asking the courts to force J&J to create equally targeted “corrective marketing” and or alternatively fund outreach efforts to […]

‘New GSK’ shows strength amid investor pressure, but Shingrix still needs to regain its footing

As activist investor Elliott Management turns up the heat on GlaxoSmithKline, CEO Emma Walmsley’s new vision for the company is showing strength. But while Glaxo’s vaccines business does gangbusters overall, its crown jewel Shingrix has yet to hit its stride after the pandemic knocked it off its course. GSK’s shingles vaccine reeled in £295 million […]

National Resilience forks over $110M for NC manufacturing site in bluebird bio cell therapy partnership

National Resilience, a venture-backed biopharma manufacturing specialist, has made waves since debuting last year with $800 million in funding. In its latest move, the new player is inking a cell therapy partnership with a high-profile partner and once again expanding its manufacturing footprint.  National Resilience and bluebird bio on Wednesday unveiled a collaboration intended to speed research, development and delivery of next-gen cell therapies. As part […]

Bristol Myers hits CAR-T manufacturing bottleneck as Abecma demand outstrips supply

After watching manufacturing problems play out for the first wave of CAR-T therapies, one might expect a smoother experience for third-to-market Bristol Myers Squibb. But the New York pharma now says it’s also hitting a production snag. Demand for Bristol Myers’ newly launched multiple myeloma CAR-T drug Abecma is outstripping capacity, company executives said during a conference call Wednesday. Approved by […]

Google’s cookie ban delay prompts sighs of relief, but pharma advertisers shouldn’t get complacent: digital media exec

With Google’s cookie ban pushed back again, pharma marketers can breathe a sigh of relief, right? Only for now, says Publicis Health Media’s chief digital officer.   Third-party tracking cookies aren’t as important to pharma as they are to consumer marketers. Automakers, for instance, can follow online car shoppers, putting targeted digital ads in buyers’ paths […]

Moderna and Novavax grapple with COVID-19 vaccine supply hiccups overseas: reports

Halfway through the pandemic’s second year, vaccine rollouts have hit their stride in some countries. Still, manufacturing problems can take an immediate toll on production and delivery timelines. Now, two COVID-19 vaccines—one authorized and the other not—are grappling with delays overseas.  Moderna and Novavax are facing separate struggles to supply their COVID-19 shots outside the U.S., according […]

‘I don’t like it:’ Biogen’s latest Alzheimer’s ad rouses fresh Aduhelm concerns—and some defense

Maybe you occasionally forget appointments or social events, or lose your train of thought in a conversation. Maybe you’re feeling depressed or overwhelmed when making a decision.  According to a online symptoms quiz from Biogen and Japanese partner Eisai, those are just a handful of signs of mild cognitive impairment (MCI), an early indication of […]

Pharma giants, led by Pfizer and J&J, play COVID card to fight global tax deal: WSJ

Pharma is already playing the COVID card.  In the face of a comprehensive global tax agreement intended to stymie opportunities for tax avoidance, industry executives and lobbyists are mounting a quiet campaign to push back against the measure, The Wall Street Journal reports.  This time around, however, pharma has a new negotiating tool: the goodwill […]

GlaxoSmithKline debuts DTC campaign for lupus med Benlysta as it looks to cement category lead

Lupus patients star in GlaxoSmithKline’s first-ever DTC ads for Benlysta, as the pharma looks to cement its founder status in the category. Three young women step up in the new “Sorry Lupus” campaign TV ads to talk about managing their condition. Instead of opting out of family and fun by saying “Sorry, I can’t,” they […]

Pfizer, Mylan escape another EpiPen lawsuit after judge scraps pharmacy chain’s antitrust complaints

Mylan and Pfizer have spent years defending their marketing of the popular epinephrine injector EpiPen. After a busy couple of months in court, the partners have now wiped their hands of another lawsuit. U.S. District Judge Daniel Crabtree granted Mylan’s motion to dismiss an antitrust lawsuit against itself and Pfizer. Specifically, the Kansas District Court tossed out a second amended class-action complaint […]